Daily intraperitoneal administration for 11 days reduced body weight gain, decreased white adipose tissue mass by approximately 35%, and reduced adipocyte size, while food intake between treated and control groups did not differ significantly
Common reactions may include pain, redness, or irritation at the injection site, mild diarrhea, nausea, itching, headache, dizziness, or a general feeling of swelling
All injections were performed under general anesthesia using ultrasound guidance by a trained physiatrist under sterile conditions
The primary risk is reduced effectiveness rather than toxicity
A: Many people pair metabolic-focused compounds with nutrition and training
Invest in a small refrigerator thermometer